attenuated virus

• Prospective Grant of Exclusive License: Live, Attenuated Virus Vaccines Against RSV, PIV, and hMPV

• FR, September 08, 2008
• Notices
• National Institutes of Health

• Fda Approves Zostavax Vaccine to Prevent Shingles in Individuals 50 to 59 Years of Age

SILVER SPRING, Md., March 24, 2011 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) today approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

• U.S. Newswire
• March 24, 2011

• Students Receive H1n1 Flu Vaccine

According to the federal Centers for Disease Control and Prevention, the attenuated virus used in the spray vaccine survives only in the cooler temperatures of nose, then dies as it enters the warmer conditions of respiratory system.

• Missoulian
• November 02, 2009

• Grants and cooperative agreements; availability, etc.: Live attenuated respiratory syncytial virus, human metapneumovirus, and parainfluenza virus vaccines; licensing opportunity, research and development,

• FR, September 14, 2004
• Notices
• National Institutes of Health

• Antidote

Measles is preventable: 99% of those who receive the two-step vaccination develop immunity. The measles vaccine uses a live attenuated virus, which means a deactivated virus that can still provoke immunity but no longer get people sick. There is a growing irrational fear of vaccinations that is not connected to fact. This fear leads to disuse of a crucial preventative. While it is understandable that parents are concerned about vaccines their child receives, the measles vaccine requires 100% compliance to effectively prevent reoccurrence and control spread of a deadly disease.

• Medical Marketing and Media
• August 11, 2009

• National Institute of Allergy and Infectious Diseases: Licensing Opportunity and Cooperative Research and Development Agreement Opportunity; Live Attenuated Vaccine to Prevent Disease Caused by West Nile Virus

• FR, March 05, 2008
• Notices
• National Institutes of Health

• Dealing with Season's Illnesses in Children

How safe is the vaccine? Didn't they do a rush job to get it out to the public quickly? Answer: There are two versions of the H1N1 vaccines. The injectable version utilizes killed H1N1 viral elements. The intranasal administered version contains a live attenuated virus. This means that the virus itself has been defanged, and as an added bonus, it can only survive in the cooler environment of the nasal cavity. For these reasons, it is not possible to develop clinical disease from either vaccine. The science involved in creating both versions is not exactly new, and it is a credit to the vaccine manufacturing industry that they were produced in time to make an impact during the current flu epidemic.

• Redlands Daily Facts
• December 02, 2009

• Bullous pemphigoid after herpes zoster vaccine administration: association or coincidence?

... vaccinations, including the hepatitis B virus (HBV) vaccine, the measles, mumps and rubella (MMR... of the Oka-Merck strain of the live, attenuated varicella-zoster virus (VZV). The vaccine has prov...

• Journal of Drugs in Dermatology
• Vol. 10 Nbr. 11, November 2011

• Grants and cooperative agreements; availability, etc.: Live attenuated vaccine to prevent West Nile virus infection in humans,

• FR, May 12, 2003
• Notices
• National Institutes of Health

• TSI announces a study being presented on the development of live-attenuated AIDS virus advances with successful primate trial.

MILFORD, Mass.--(BUSINESS WIRE)--Nov. 9, 1994--TSI Corp., a subsidiary of Genzyme Transgenics Corp. (NASDAQ: GZTC), announces a study being presented ...

• Business Wire
• November 09, 1994